Rovalpituzumab Biosimilar - Research Grade
Product Specifications
Specifications
Detects human DLL3. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Rovalpituzumab.
UniProt
Q9NYJ7
Species Reactivity
Human
Target
DLL3
Isotype
IgG1
Applications
Functional Assays
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
5mg/mL
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE
Buffer
ICH3002
Shipping Conditions
Blue ice
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Product Datasheet
https://ichor.bio/productpdf/print/index/url_key/rovalpituzumab-biosimilar-research-grade-ich5048/
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Applications Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Isotype Control
https://ichor.bio/product/bulk-human-igg1-isotype-control-ib1-ich2254/
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GFPT2 Antibody - N-terminal region: HRP (ARP42214_P050-HRP)
CDS1 (Phosphatidate Cytidylyltransferase 1, CDP-DAG Synthase 1, CDP-DG Synthase 1, CDP-diacylglycerol Synthase 1, CDS 1, CDP-diglyceride Pyrophosphorylase 1, CDP-diglyceride Synthase 1, CTP:phosphatidate Cytidylyltransferase 1, CDS) (MaxLight 650)
CDS1 (Phosphatidate Cytidylyltransferase 1, CDP-DAG Synthase 1, CDP-DG Synthase 1, CDP-diacylglycerol Synthase 1, CDS 1, CDP-diglyceride Pyrophosphorylase 1, CDP-diglyceride Synthase 1, CTP:phosphatidate Cytidylyltransferase 1, CDS) (MaxLight 650)